Moreover, the activation of pyroptosis in PASMCs, which is related to pulmonary fibrosis induced by hypoxia, was alleviated by treatment with Caspase-1 inhibitors (Zhang et al. 2020). Here, CASP1 is linked to pulmonary fibrosis.